How GAVI is funded

GAVI’s unique funding model draws heavily on private sector thinking to help overcome the historic limitations to development funding for immunisation
GAVI’s two funding streams, innovative finance and direct contributions account for 37% and 63% respectively of the Alliance’s overall funding portfolio.
Innovative finance includes the International Finance Facility for Immunisation (IFFIm) and the Advance Market Commitment (AMC).
Direct contributions include grants and agreements from donor governments, and personal and private sector philanthropy facilitated by the GAVI Campaign.

Direct contributions

Multi-year pledges and commitments are crucial to sustaining GAVI's ongoing programmes and its ability to fund new vaccines.

Innovative finance

GAVI has pioneered several innovative funding mechanisms to deliver large-scale 'predictable' funds for its immunisation programmes.

Public-private partnerships

Corporations, private individuals & foundations play a vital role in meeting GAVI needs, accounting for 24% of 2000 to 2010 funding.

GAVI’s unique funding model draws heavily on private sector thinking to help overcome the historic limitations to development funding for immunisation